Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

focafoca99 Apr. 28 at 5:42 AM

$JNJ entered the calendar for Bernstein's Strategic Decisions Conference with a planned company appearance. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-participate-b6d983

0 · Reply

Suite510 Apr. 28 at 1:20 AM

$JNJ $SPX $SPY $ABT oh this almost looks like a JNJ type verdict, guessing a real bankruptcy still a possibility 🤷🤣 A jury in Georgia has ordered Monsanto parent Bayer to pay nearly $2.1 billion in damages to a man who says the company’s Roundup weed killer caused his cancer.

0 · Reply

NeoZerolag Apr. 27 at 11:16 PM

$FN $LCID $CAST $JNJ 7

0 · Reply

LiveCommander Apr. 27 at 10:30 PM

Question: where's the math? Bullish narratives stacking on $IGV momentum and AI productivity ignore base-rate exhaustion signals 📊 Risk assessment: melt-up tape, but vol skew is cheap. Positioning advice: trim delta into strength, hedge via puts on $XLK, rotate to defensives like $PG, $JNJ for ballast.

0 · Reply

LiveCommander Apr. 27 at 10:13 PM

Question: where's the actual price discovery edge here? Superforecaster consensus ≠ deep two-way liquidity. Until institutional flow validates these benchmarks, treat as signal, not hedge instrument. 🛡️ Stay sized small, demand wider spreads. $CME $ICE $JNJ

0 · Reply

_AceZerolag Apr. 27 at 10:00 PM

$IRDM $INFQ $JNJ $INTU mm

0 · Reply

DragonAlgo Apr. 27 at 9:57 PM

🐉 $JNJ PUT — DragonAlgo® Signal Contract: JNJ PUT Expiry: 2026-05-01 | Strike: $225.00 | Type: PUT Option Plan (premium): Entry: $2.29 Stop: $1.65 TP1: $2.97 TP2: $3.88 TP3: $5.48 🔗 https://dragonalgo.com

0 · Reply

ElliottwaveForecast Apr. 27 at 9:35 PM

Can you identify when a pullback is actually creating a high‑probability buy zone? $JNJ is heading into the 227.8–215.8 area, where buyers are expected to show up. Learn this skill and apply it to any market. Check out this 👉 https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area #elliottwave #stocks

0 · Reply

focafoca99 Apr. 27 at 9:13 PM

$JNJ received FDA Priority Review for IMAAVY in warm autoimmune hemolytic anemia. https://www.rapidticker.com/news/jnj-fda-grants-priority-review-for-09369e

0 · Reply

LiveCommander Apr. 27 at 9:01 PM

Risk assessment: $C parabolic extension without volume confirmation flags exhaustion. Reward/risk skewed unfavorably at these levels 📊 Positioning advice: Trim into strength, trail stops below prior pivot. Rotate proceeds toward defensives like $JNJ or $PG. Chasing momentum here offers poor expectancy.

0 · Reply

Johnson & Johnson to Participate in the Bernstein's 42nd Annual Strategic Decisions Conference

Apr 27, 2026, 11:03 AM EDT - 16 hours ago

J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 8:03 AM EDT - 19 hours ago

FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)

Apr 24, 2026, 4:30 PM EDT - 3 days ago

Johnson & Johnson to launch on TrumpRx with four of its prescription drugs, CBS News reports

Apr 23, 2026, 6:44 PM EDT - 4 days ago

Cramer says look to these 4 stocks to go with your high-flying tech names

CAH CVS UNH

Apr 23, 2026, 10:00 AM EDT - 4 days ago

Johnson & Johnson Transcript: AGM 2026

Apr 22, 2026, 8:05 AM EDT - 5 days ago

IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

Apr 22, 2026, 4:00 AM EDT - 5 days ago

Johnson & Johnson Announces CE Mark Approval for the New ETHICON™ 4000 Stapler

Apr 21, 2026, 4:22 PM EDT - 6 days ago

Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Apr 21, 2026, 7:45 AM EDT - 6 days ago

Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026

Apr 17, 2026, 10:36 PM EDT - 10 days ago

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

Apr 17, 2026, 7:00 PM EDT - 10 days ago

U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims

Apr 16, 2026, 10:16 AM EDT - 11 days ago

Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

LLY MGTX

Apr 15, 2026, 4:11 PM EDT - 12 days ago

Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference

Apr 15, 2026, 1:43 PM EDT - 12 days ago

These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results

Apr 15, 2026, 12:37 PM EDT - 12 days ago

Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst

Apr 14, 2026, 10:51 AM EDT - 13 days ago

Johnson & Johnson CFO on the company's robotic surgical system

Apr 14, 2026, 10:30 AM EDT - 13 days ago

Tuesday's Morning Movers: ORCL & BE Extend Partnership, KMX & JNJ Earnings

ORCL BE KMX

Apr 14, 2026, 8:30 AM EDT - 13 days ago

Johnson & Johnson Earnings Call Transcript: Q1 2026

Apr 14, 2026, 6:55 AM EDT - 13 days ago

J&J raises guidance for 2026 on strong start to the year

Apr 14, 2026, 6:25 AM EDT - 13 days ago

J&J's first-quarter profit beats estimates even as Stelara sales disappoint

Apr 14, 2026, 6:21 AM EDT - 13 days ago

Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%

Apr 14, 2026, 6:20 AM EDT - 13 days ago

Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Apr 14, 2026, 6:20 AM EDT - 13 days ago

J&J's First-Quarter Sales Grow on Cancer-Drug Strength

Apr 13, 2026, 11:36 AM EDT - 14 days ago

Dow Jones Stocks In Spotlight: JPMorgan, Johnson & Johnson Among This Week's Earnings Reports

JPM DIA TRV

Apr 12, 2026, 2:00 PM EDT - 15 days ago

Goldman Sachs, Bank of America, JP Morgan, Netflix, J&J, Producer Prices, and More to Watch This Week

NFLX BAC GS JPM

Apr 10, 2026, 8:00 AM EDT - 17 days ago

Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision

Apr 9, 2026, 7:57 AM EDT - 18 days ago

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Apr 8, 2026, 10:41 AM EDT - 19 days ago

Buy Johnson & Johnson Ahead of Earnings. The Stock's Run-Up Isn't Over.

Apr 7, 2026, 8:00 AM EDT - 20 days ago

Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe

Mar 30, 2026, 9:14 AM EDT - 4 weeks ago

Royalty Pharma and J&J partner to develop autoimmune treatment

RPRX

Mar 28, 2026, 10:00 AM EDT - 4 weeks ago

ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

Mar 27, 2026, 4:46 PM EDT - 4 weeks ago

Johnson & Johnson (JNJ) Price Forecast: Bull Flag Signals Strength

Mar 27, 2026, 6:31 AM EDT - 4 weeks ago

Johnson & Johnson's DARZALEX® (daratumumab) becomes the first oncology injectable approved for administration by patients or caregivers

Mar 19, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: ORCL, JNJ, SBUX

ORCL SBUX

Mar 19, 2026, 9:35 AM EDT - 5 weeks ago

JNJ Stock's Re-Rating: When The Market Finally Sees A Different Company

Mar 18, 2026, 2:23 PM EDT - 5 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK LLY

Mar 18, 2026, 1:17 PM EDT - 5 weeks ago

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Mar 18, 2026, 8:31 AM EDT - 5 weeks ago

US FDA approves J&J's oral psoriasis pill

Mar 18, 2026, 7:49 AM EDT - 5 weeks ago

FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Mar 16, 2026, 11:00 AM EDT - 6 weeks ago

Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch

Mar 13, 2026, 12:35 PM EDT - 6 weeks ago

Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Mar 12, 2026, 8:00 AM EDT - 6 weeks ago

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

Mar 10, 2026, 11:30 AM EDT - 6 weeks ago

Johnson & Johnson Transcript: Barclays 28th Annual Global Healthcare Conference

$Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line$

Mar 5, 2026, 3:55 PM EST - 7 weeks ago

Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line

Mar 5, 2026, 2:21 PM EST - 7 weeks ago

US FDA approves JNJ's blood cancer drug

Mar 4, 2026, 6:07 PM EST - 7 weeks ago

Johnson & Johnson launches website for direct-to-consumer sales

Mar 3, 2026, 11:10 AM EST - 7 weeks ago

Johnson & Johnson Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 8:03 AM EST - 7 weeks ago

Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)

Mar 2, 2026, 4:30 PM EST - 2 months ago

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Feb 26, 2026, 2:30 PM EST - 2 months ago

Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer

Feb 24, 2026, 4:03 PM EST - 2 months ago

Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

Feb 23, 2026, 11:35 AM EST - 2 months ago

Does JNJ Stock Still Offer Value?

Feb 23, 2026, 10:43 AM EST - 2 months ago

Bayer files lawsuit against Johnson & Johnson, Janssen Biotech

Jan 21, 2026, 8:30 AM EST - 3 months ago

Johnson & Johnson Earnings Call Transcript: Q4 2025

Jan 12, 2026, 11:15 AM EST - 3 months ago

Johnson & Johnson Transcript: 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 11:15 AM EST - 5 months ago

Johnson & Johnson Transcript: Citi Annual Global Healthcare Conference 2025

Nov 17, 2025, 10:40 AM EST - 5 months ago

Johnson & Johnson Transcript: Wolfe Research Healthcare Conference 2025

Nov 11, 2025, 11:00 AM EST - 5 months ago

Johnson & Johnson Transcript: UBS Global Healthcare Conference 2025

Nov 11, 2025, 10:30 AM EST - 5 months ago

Johnson & Johnson Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Oct 14, 2025, 8:30 AM EDT - 6 months ago

Johnson & Johnson Earnings Call Transcript: Q3 2025

Sep 24, 2025, 1:10 PM EDT - 7 months ago

Johnson & Johnson Transcript: Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 10, 2025, 11:30 AM EDT - 8 months ago

Johnson & Johnson Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 11:50 AM EDT - 8 months ago

Johnson & Johnson Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Jul 16, 2025, 8:30 AM EDT - 10 months ago

Johnson & Johnson Earnings Call Transcript: Q2 2025

Jun 11, 2025, 3:20 PM EDT - 11 months ago

Johnson & Johnson Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 9:00 AM EDT - 11 months ago

Johnson & Johnson Transcript: Bernstein 41st Annual Strategic Decisions Conference 2025

May 20, 2025, 1:35 PM EDT - 1 year ago

Johnson & Johnson Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 13, 2025, 1:40 PM EDT - 1 year ago

Johnson & Johnson Transcript: Bank of America 2025 Health Care Conference

Apr 24, 2025, 10:00 AM EDT - 1 year ago

Johnson & Johnson Transcript: AGM 2025

Apr 15, 2025, 8:30 AM EDT - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q1 2025

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Johnson & Johnson Transcript: Investor Update

Mar 4, 2025, 11:10 AM EST - 1 year ago

Johnson & Johnson Transcript: TD Cowen 45th Annual Healthcare Conference

Jan 22, 2025, 8:00 AM EST - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q4 2024

Jan 13, 2025, 12:00 PM EST - 1 year ago

Johnson & Johnson Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Nov 18, 2024, 10:55 AM EST - 1 year ago

Johnson & Johnson Transcript: Stifel 2024 Healthcare Conference

Nov 12, 2024, 10:30 AM EST - 1 year ago

Johnson & Johnson Transcript: Guggenheim Global Healthcare Conference

Oct 15, 2024, 8:30 AM EDT - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q3 2024

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Johnson & Johnson Transcript: 2024 Wells Fargo Healthcare Conference

Sep 4, 2024, 10:45 AM EDT - 1 year ago

Johnson & Johnson Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Jul 17, 2024, 8:30 AM EDT - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q2 2024

Jun 12, 2024, 2:00 PM EDT - 2 years ago

Johnson & Johnson Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 29, 2024, 1:30 PM EDT - 2 years ago

Johnson & Johnson Transcript: Bernstein’s 40th Annual Strategic Decisions Conference

May 15, 2024, 11:00 AM EDT - 2 years ago

Johnson & Johnson Transcript: RBC Capital Markets Global Healthcare Conference

May 14, 2024, 4:40 PM EDT - 2 years ago

Johnson & Johnson Transcript: BofA Healthcare Conference

Apr 25, 2024, 10:00 AM EDT - 2 years ago

Johnson & Johnson Transcript: AGM 2024

Apr 16, 2024, 8:30 AM EDT - 2 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2024

Apr 5, 2024, 8:30 AM EDT - 2 years ago

Johnson & Johnson Transcript: M&A Announcement

Mar 13, 2024, 10:45 AM EDT - 2 years ago

Johnson & Johnson Transcript: Barclays 26th Annual Global Healthcare Conference

Mar 12, 2024, 1:00 PM EDT - 2 years ago

Johnson & Johnson Transcript: Leerink Partners Global Biopharma Conference 2024

Mar 4, 2024, 11:10 AM EST - 2 years ago

Johnson & Johnson Transcript: TD Cowen 44th Annual Health Care Conference

Jan 23, 2024, 8:30 AM EST - 2 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2023

Jan 8, 2024, 12:45 PM EST - 2 years ago

Johnson & Johnson Transcript: J.P. Morgan 2024 42nd Annual Healthcare Conference

Dec 5, 2023, 10:00 AM EST - 2 years ago

Johnson & Johnson Transcript: Investor Update

Oct 17, 2023, 8:30 AM EDT - 2 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2023

Sep 13, 2023, 10:10 AM EDT - 2 years ago

Johnson & Johnson Transcript: Morgan Stanley 21st Annual Global Healthcare Conference

Sep 7, 2023, 10:15 AM EDT - 2 years ago

Johnson & Johnson Transcript: 2023 Wells Fargo Healthcare Conference

Aug 15, 2023, 2:00 PM EDT - 2 years ago

Johnson & Johnson Transcript: Genomics 2.0 and MedTech Innovations Summit

Jul 20, 2023, 8:30 AM EDT - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2023

Jun 13, 2023, 4:20 PM EDT - 3 years ago

Johnson & Johnson Transcript: Goldman Sachs 44th Annual Global Healthcare Conference

Apr 18, 2023, 8:30 AM EDT - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2023

Jan 24, 2023, 8:30 AM EST - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2022

Jan 9, 2023, 12:45 PM EST - 3 years ago

Johnson & Johnson Transcript: JPMorgan Healthcare Conference

Nov 1, 2022, 8:00 AM EDT - 3 years ago

Johnson & Johnson Transcript: M&A Announcement

Oct 18, 2022, 8:00 AM EDT - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2022

Jul 18, 2022, 8:46 PM EDT - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2022

Apr 19, 2022, 6:24 AM EDT - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2022

Jan 25, 2022, 12:40 PM EST - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2021

Nov 11, 2021, 7:00 PM EST - 4 years ago

Johnson & Johnson Transcript: Investor Update

Oct 18, 2021, 8:00 PM EDT - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2021

Jul 21, 2021, 2:00 AM EDT - 5 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2021

Jun 23, 2021, 8:25 AM EDT - 5 years ago

Johnson & Johnson Transcript: ESG Update

Apr 21, 2021, 8:00 PM EDT - 5 years ago

Johnson & Johnson Transcript: AGM 2021

Apr 20, 2021, 8:45 AM EDT - 5 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2021

Jan 26, 2021, 3:32 AM EST - 5 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2020

Oct 13, 2020, 3:34 AM EDT - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2020

Jun 27, 2020, 3:38 AM EDT - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2020

Apr 14, 2020, 3:39 AM EDT - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2020

Jan 22, 2020, 8:30 AM EST - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2019

Oct 15, 2019, 8:30 AM EDT - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2019

Jul 16, 2019, 8:30 AM EDT - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2019

Apr 16, 2019, 8:30 AM EDT - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2019

Jan 22, 2019, 8:30 AM EST - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2018

Oct 16, 2018, 8:30 AM EDT - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2018

Jul 17, 2018, 8:30 AM EDT - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2018

May 16, 2018, 8:40 AM EDT - 8 years ago

Johnson & Johnson Transcript: Investor Day 2018

Apr 17, 2018, 8:30 AM EDT - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2018

Jan 23, 2018, 8:30 AM EST - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2017

Oct 17, 2017, 8:30 AM EDT - 9 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2017

Jul 18, 2017, 8:30 AM EDT - 9 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2017

Apr 18, 2017, 8:30 AM EDT - 9 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2017

Jan 24, 2017, 8:30 AM EST - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2016

Oct 18, 2016, 8:30 AM EDT - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2016

Jul 19, 2016, 8:30 AM EDT - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2016

Apr 19, 2016, 8:30 AM EDT - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2016

Jan 26, 2016, 8:30 AM EST - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2015

Oct 13, 2015, 8:30 AM EDT - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2015

Jul 14, 2015, 8:30 AM EDT - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2015

Apr 14, 2015, 8:30 AM EDT - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2015

focafoca99 Apr. 28 at 5:42 AM

$JNJ entered the calendar for Bernstein's Strategic Decisions Conference with a planned company appearance. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-participate-b6d983

0 · Reply

Suite510 Apr. 28 at 1:20 AM

0 · Reply

NeoZerolag Apr. 27 at 11:16 PM

$FN $LCID $CAST $JNJ 7

0 · Reply

LiveCommander Apr. 27 at 10:30 PM

0 · Reply

LiveCommander Apr. 27 at 10:13 PM

0 · Reply

_AceZerolag Apr. 27 at 10:00 PM

$IRDM $INFQ $JNJ $INTU mm

0 · Reply

DragonAlgo Apr. 27 at 9:57 PM

0 · Reply

ElliottwaveForecast Apr. 27 at 9:35 PM

0 · Reply

focafoca99 Apr. 27 at 9:13 PM

$JNJ received FDA Priority Review for IMAAVY in warm autoimmune hemolytic anemia. https://www.rapidticker.com/news/jnj-fda-grants-priority-review-for-09369e

0 · Reply

LiveCommander Apr. 27 at 9:01 PM

0 · Reply

TGZerolag Apr. 27 at 8:38 PM

$INTU $MX $JNJ $SQM season

0 · Reply

Buy_SoFi Apr. 27 at 7:34 PM

$TLTFF <---- 👀 More and more eyes on this gem. Don't get me wrong, there is still some de-risking to do but by that time I expect the price to be double or triple what it is today. Volume increasing daily which is nice to see $MRK $JNJ $IBRX $CGON

0 · Reply

maq34 Apr. 27 at 5:19 PM

$ATRC $JNJ $MDT $HIMS $PFE https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/ https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/

0 · Reply

AltcoinsPumpAndDump2024 Apr. 27 at 4:45 PM

$JNJ what’s up with this pos?

0 · Reply

NRG8 Apr. 27 at 4:17 PM

$CRWV $COIN $CRSP $LLY $JNJ

0 · Reply

Buy_SoFi Apr. 27 at 3:01 PM

$TLTFF 👀Theralase Technologies: Ruvidar and Rutherin showing amazing results. NMIBS, MIBC, Lung, Brain, Pancreatic, Colorectal AND HSV treatment in the pipeline. One of the most promising biotech stock in the world today. $IBRX $MRK $JNJ $GILD

0 · Reply

maikl_211 Apr. 27 at 2:30 PM

$ORCL $XOM $JNJ $ASML $MA

0 · Reply

ElliottwaveForecast Apr. 27 at 11:20 AM

$JNJ Buyers looking to take control from daily #Bluebox to new high or at least 3 swings bounce The corrective pullback reach between 227.8 - 215.8 area and expect soon to turn higher to extend January-2025 rally in daily. Buyers at least get 3 swing rally or above 256 or higher. https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area/ #Elliottwave #JNJ

0 · Reply

Suite510 Apr. 27 at 11:14 AM

$JNJ $SPX $SPY $ABT Rescheduled Talc mediation is today, whereas Junk n Junk has LOST every single talc trial since March 2025 rut ro lol 😂

0 · Reply

AnthonyTradingWithJesus Apr. 26 at 10:19 PM

$JNJ $BBAI $MSFT $MARA $INTC

0 · Reply

stockanalysis_ Apr. 26 at 3:18 PM

Biggest Pharmaceutical Stocks: $LLY $JNJ $ABBV $AZN $MRK Download this screener: https://stockanalysis.com/list/pharmaceutical-stocks/?ref=saveontrading

0 · Reply

DragonAlgo Apr. 26 at 1:39 PM

🐉 $JNJ PUT — DragonAlgo® Signal Contract: JNJ PUT Expiry: 2026-05-01 | Strike: $225.00 | Type: PUT Option Plan (premium): Entry: $1.76 Stop: $1.27 TP1: $2.29 TP2: $2.99 TP3: $4.22 🔗 https://dragonalgo.com

0 · Reply

Market Cap	547.64B
Revenue (ttm)	94.19B
Net Income (ttm)	26.80B
EPS (ttm)	N/A
PE Ratio	21.50
Forward PE	19.93
Profit Margin	28.46%
Debt to Equity Ratio	0.48

Volume	7,897,800
Avg Vol	8,279,580
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	20%
Beta	0.34
Analysts	Strong Sell
Price Target	$259.50